Predict your next investment

Venture Capital
t2c2capital.com

See what CB Insights has to offer

Investments

14

Portfolio Exits

4

Funds

3

About T2C2 Capital

T2C2 Capital is a venture capital firm based in Montreal, Quebec.

T2C2 Capital Headquarter Location

1550 Metcalfe Street Suite 502

Montreal, Quebec, H3A 1X6,

Canada

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing T2C2 Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find T2C2 Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

T2C2 Capital Investments

14 Investments

T2C2 Capital has made 14 investments. Their latest investment was in Enobia Pharma as part of their Series B on September 9, 2007.

CBI Logo

T2C2 Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/20/2007

Series B

Enobia Pharma

$40.1M

Yes

CTI Life Sciences Fund, Desjardins, Fonds de Solidarite FTQ, Lothian Partners, and OrbiMed Advisors

11/30/2003

Series B

IatroQuest

$12.57M

No

Desjardins Capital, In-Q-Tel, and Undisclosed Investors

1

11/24/2003

Series B

Chronogen

$12.95M

No

Desjardins Capital, and Undisclosed Investors

1

8/31/2002

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/11/2002

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/20/2007

11/30/2003

11/24/2003

8/31/2002

1/11/2002

Round

Series B

Series B

Series B

Series A

Series C

Company

Enobia Pharma

IatroQuest

Chronogen

Subscribe to see more

Subscribe to see more

Amount

$40.1M

$12.57M

$12.95M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

CTI Life Sciences Fund, Desjardins, Fonds de Solidarite FTQ, Lothian Partners, and OrbiMed Advisors

Desjardins Capital, In-Q-Tel, and Undisclosed Investors

Desjardins Capital, and Undisclosed Investors

Sources

1

1

10

10

T2C2 Capital Portfolio Exits

4 Portfolio Exits

T2C2 Capital has 4 portfolio exits. Their latest portfolio exit was Cytochroma on January 10, 2013.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/10/2013

Acquired

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

1/10/2013

00/00/0000

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

T2C2 Capital Fund History

3 Fund Histories

T2C2 Capital has 3 funds, including T2C2/Bio2000.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2001

T2C2/Bio2000

Early-Stage Venture Capital

$104M

1

12/31/1997

T2C2/Bio

Subscribe to see more

$99M

10

12/31/1997

T2C2/Info

Subscribe to see more

$99M

10

Closing Date

12/31/2001

12/31/1997

12/31/1997

Fund

T2C2/Bio2000

T2C2/Bio

T2C2/Info

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Amount

$104M

$99M

$99M

Sources

1

10

10

T2C2 Capital Team

2 Team Members

T2C2 Capital has 2 team members, including current President, Bernard Coupal.

Name

Work History

Title

Status

Bernard Coupal

President

Current

Chantal Lachapelle

Controller

Current

Name

Bernard Coupal

Chantal Lachapelle

Work History

Title

President

Controller

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.